Prof. Dr. Xuehao Wang, MD
Dr. Prof. Wang received his medical master degree from Nanjing Medical University in 1982. He was trained on liver surgery in the University of Pittsburgh-Pittsburgh between September 1983 and October 1985.
Dr. Prof. Wang is an Academician of the Chinese Academy of Engineering, Professor (grade A), tutor of doctoral candidates, chief physician. Currently he is the director of the Institute of Liver Surgery, the First Affiliated Hospital of Nanjing Medical University, director of the clinical key discipline of organ transplantation of the National Health and Family Planning Commission (NHFPC), director of key laboratory, member of the human organ transplantation expert group, chief of the Group of Transplant Immunology, Chinese Medical Association, director of Liver Transplantation Center of Jiangsu Province, and vice president of Medical Association of Jiangsu Province. He is the member of the editorial boards of top journals including HBPT INT, WJG, Chinese Journal of Organ Transplantation, Chinese Journal of Digestive Surgery, and Chinese Journal of Bases and Clinics in General Surgery.
Dr. Wang is a pioneer in living donor liver transplantation (LDLT) in mainland China and also one of the few scholars who adopted LDLT in clinical practices worldwide. In mainland China, Dr. Wang for the first time established a standard technical system for LDLT and promoted this technique nationwide. His unremitting efforts paved the way for the wide adoption of LDLT. His innovative insights about the basics and clinical application of living related liver donor transplantation for Wilson's disease bring new light to the surgical treatment of this disease. Early in June 1986, he was the first Chinese author that reported the role of hepatic artery angiography with iodinated oil in the diagnosis of liver cancer, which paved the way for the modern interventional treatment for liver cancer in China. In November 2012, under his leadership and supervision, the resected liever specimens carrying hemangioma, which had been discarded in conventional practices, were transplanted into liver cancer patients, and the outcomes were quite good. This attempt provided new insight for the maximal use of marginal liver in liver transplantation. In recent years, he has carried out or completed 4 research projects supported by the National Natural Science Fund and/or National "Eighth Five-year" Science and Technology Research Program, over 30 projects supported by provincial or ministerial research funds, and over 30 projects supported by the provincial health authorities or the Nanjing Medical University. The overall grants exceed 20 million RMB yuan. As the principal investigator, he was the winner of one National Scientific and Technological progress Award (second prize), one Jiangsu Provincial Science and Technology Progress Award (first prize), and six provincial or ministerial research awards (second prizes). His honorable titles included "National Health System Excellent Worker", "Norman Bethune-style Medical Staff", "Advanced Worker", and "Nanjing 's City Hero in Science and Technology". He was the winner of the "Award for Outstanding Contributions in Medicine" and the "Jiangsu Province Outstanding Medical Award". In 2015, he won the noble title of "National Advanced Worker". He has obtained 3 invention patents. He has published over 400 scientific articles, among which 85 were published in SCI-indexed journals (as the first author or corresponding author). He is the editor, deputy editor, or contributor of 20 monographs. Among his students, 1 has been titled as the Cheung Kong Scholar, 1 was the winner of the National Outstanding Youth Fund, 1 was listed in the Jiangsu Province Leading Talents and 5 as Key Talents, 10 were listed in the Jiangsu Province 333 Engineering Talents, and 11 were listed as the Peak Talents in Six Key Disciplines.
Yinghao Sun, MD
Dr. Yinghao Sun is a Chief Physician, PhD Supervisor, an Academician of the Chinese Academy of Engineering, the Chief Scientist of 973 programs, and the winner of Ho Leung Ho Lee Foundation Award. He is currently the President of the Second Military Medical University, and he is the Director of the Department of Urology. He is also the Director of the Research Institute for Prostatic Disease of the PLA, and the Director of Changhai da Vinci Robotic Surgery Training Center.
Dr. Sun was the Former Chairman of the Urological Association of Asia, the Executive Director of Chinese Medical Association, the Chairman of the Urology Branch of the China Medical Association, the Vice President of the Chinese Medical Doctor Association, the President-Elect of Chinese the Urological Doctor Association, the President-Elect of the Association of China Robotic Surgery, the Chairman of the Urology Branch of the China Association of Medical Equipment, the President of the Urological Association of the PLA, the Vice President of the Shanghai Association for Science & Technology, the Vice President of Shanghai Medical Association, and the President of the Urology Branch of the Shanghai Medical Doctor Association. He has also launched the Asian Journal of Urology and served as Editor-in-Chief of the Chinese Journal of Urology and the Chinese Journal of Endourology.
Dr. Sun specializes in clinical diagnosis, treatment, and research of urological tumors and urolithiasis, as well as practice and innovate techniques for minimally invasive urological techniques. Dr. Sun has been awarded one First Prize, and two Second Prize for National Science and Technology Progress Award. Additionally, he has earned 9 provincial and ministerial level scientific achievement awards (all as first participant). Dr. Sun is the Principal investigator of 23 scientific programs such as the National Basic Research Program (973 program), the National Science Fund for Distinguished Young Scholars, and etc. He is the owner of 27 national utility model patents, and 23 national invention patents. Dr. Sun has published more than 500 articles as first author or the corresponding author, with 177 total articles published in Science Citation Index Expanded journals. He is the Chief Editor of 20 books, such as The Training Courses of Urological Laparoscopy, Clinical diagnosis, and Treatment of Prostate Cancer, and etc. Dr. Sun is also the laureate for the Alexander Savchuk Award in Oncology Research, Wu Jieping Medical Innovation Award, Top 10 Sci-Tec Elite for Shanghai, and has been awarded the prize for Scientific and Technological Progress sponsored by Ho Leung Ho Lee Foundation. He also received the Merit Citation Class II award twice and Merit Citation Class III award once.
Prof. Dr. Jianxing He, MD, FACS
Professor He is the Director and Professor of the Thoracic Surgery Department, First Affiliated Hospital of Guangzhou Medical University, Guangzhou Institute of Respiratory Diseases (GIRD), as well as the President of the First Affiliated Hospital of Guangzhou Medical University, China. He completed his medical studies at Guangzhou Medical University, and attained a higher research doctorate in thoracic surgery at the Guangdong Institute of Cardiovascular Disease while concurrently acting as the Deputy Director of the Thoracic Surgery Department of Guangzhou Medical University. Professor He later became a Fellow of the American College of Surgeons. His has the world-largest clinical experience in video-assisted thoracic surgery and non-intubation minimally invasive thoracic surgery. His other appointments include being the Primary Investigator of the National Key Laboratory of Respiratory Disease, Chief Advisor of National Ministry of Health Clinical Invasive Pathway Technique Advisory Board, Chairman of National Evaluation Committee for Endoscopic Skills, President of Guangdong Thoracic Surgeon Society, Chief Physician and Director of the thoracic surgery department of the First Hospital Affiliated to Guangzhou Medical University, and Primary Investigator of Translational Medicine Lab in the First Affiliated Hospital of Guangzhou Medical University. Professor He has published more than 200 scientific papers in thoracic surgery, including a seminal paper published in Lancet regarding a molecular assay he developed to predict survival in resected non-squamous, non-small-cell lung cancer. He also established the Asian-Pacific Lung Cancer Specimen and Tissue Bank, which has collected more than 20,000 samples including 18 multi-resisted lung cancer cell lines. Professor He has an extensive and impressive array of research experience, currently undertaking more than 30 scientific projects supported by National 863 Program and National Science Foundation.